Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke

American Heart Journal

Volumn 169, Issue 1, 2015, Pages 39-44.e2

  Navar Boggan, Ann Marie ^a   Rymer, Jennifer A ^a   Piccini, Jonathan P ^a   Shatila, Wassim ^a   Ring, Lauren ^a   Stafford, Judith A ^a   Al Khatib, Sana M ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIXABAN; DABIGATRAN; ENOXAPARIN; HEPARIN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; AUTOMATION; CEREBROVASCULAR ACCIDENT; CHA2DS2 SCORE; CHADS2 SCORE; CLASSIFICATION ALGORITHM; COMORBIDITY ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HIGH RISK PATIENT; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION STUDY; ALGORITHM; ATRIAL FIBRILLATION; PROCEDURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84925884281     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.09.014     Document Type: Article

References (10)

1. Nieuwlaat R, Capucci A, Lip GY, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006;27(24):3018-26.
2. Piccini JP, Hernandez AF, Zhao X, et al. Quality of care for atrial fibrillation among patients hospitalized for heart failure. J Am Coll Cardiol 2009;54(14):1280-9.
3. Estes III NA, Halperin JL, Calkins H, et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation 2008;117(8):1101-20.
4. Pay for performance. Health Policy Brief. Health affairs. 2012. [Accessed 10/15/2013 from: www.healthaffairs.org. http://www. rwjf.org/content/dam/farm/reports/issue-briefs/2012/ rwjf401782].
5. The Affordable Care Act: lowering medicare costs by improving care. Centers for Medicare and Medicaid Services accessed 10/5/2013. 2012. [http://www.cms.gov/apps/files/aca-savingsreport-2012.pdf].
6. Piccini JP, Hammill BG, Sinner MF, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012;5 (1):85-93.
7. Rothendler JA, Rose AJ, Reisman JI, et al. Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent populationlevel risk factor prevalence and distribution of CHADS2 scores. Am J Cardiovasc Dis 2012;2(3):184-91.
8. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285(22): 2864-70.
9. Olesen JB, Fauchier L, Lane DA, et al. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Chest 2012;141 (1):147-53.
10. Jensen PN, Johnson K, Floyd J, et al. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012;21:141-7.